GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (XSWX:BANB) » Definitions » 3-Year EPS without NRI Growth Rate

Bachem Holding AG (XSWX:BANB) 3-Year EPS without NRI Growth Rate : 10.30% (As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Bachem Holding AG 3-Year EPS without NRI Growth Rate?

Bachem Holding AG's EPS without NRI for the six months ended in Jun. 2024 was CHF0.48.

During the past 12 months, Bachem Holding AG's average EPS without NRI Growth Rate was 18.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Bachem Holding AG was 41.50% per year. The lowest was -45.70% per year. And the median was 13.40% per year.


Competitive Comparison of Bachem Holding AG's 3-Year EPS without NRI Growth Rate

For the Chemicals subindustry, Bachem Holding AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bachem Holding AG's 3-Year EPS without NRI Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bachem Holding AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's 3-Year EPS without NRI Growth Rate falls into.



Bachem Holding AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Bachem Holding AG  (XSWX:BANB) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Bachem Holding AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Bachem Holding AG Business Description

Industry
Traded in Other Exchanges
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.

Bachem Holding AG Headlines

No Headlines